Metagenomic next-generation sequencing (NGS) of cerebrospinal fluid (CSF) has the potential to identify a broad range of pathogens in a single test. We enrolled 204 pediatric and adult patients at ...
This story was updated on 18 April 2017 to correct an error. Cerebrospinal fluid biomarkers of Alzheimer’s disease have transformed clinical research, but ...
Director, Molecular Microbiology Assistant Director, Clinical Microbiology and Immunoserology Laboratories Nationwide Children's Hospital Associate Professor - Clinical, College of Medicine, The Ohio ...
Studied since the early 1990s, cerebrospinal fluid Aβ42 is the most established fluid marker for detecting early Alzheimer’s disease, yet trying to turn it into a clinically certified, broad-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results